- Apogee details path to $10.9B AbbVie deal; UK starts drug pricing pilotPlus news about Brii Biosciences. 💰 How AbbVie got Apogee: The Chicago-area drug giant snagged Apogee Therapeutics for $10.9 billion last month after years of talking with the biotech. AbbVie held…Endpoints · 22d ago↗ source
- Gene editing developer Scribe plots an IPOThe California drugmaker, which has collaborations in place with Biogen, Sanofi and Eli Lilly, could be the 14th biotech to go public in 2026.BioPharma Dive · 22d ago↗ source
- Novartis to acquire ADC developer in a deal worth up to $1.5BThe deal hands over two ADCs with a different mechanism of action targeting cell growth, and marks Novartis' entry into ADC development.BioPharma Dive · 22d ago↗ source